Tempus AI, Inc.
TEMHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeTempus AI, Inc. operates as a healthcare technology company in the United States. With a market capitalization of $9.42B, it sits in mid-cap territory. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$9.42B
Beta
3.46
P/E (TTM)
—
P/E (Fwd)
-662.75
EPS (TTM)
$-1.68
EPS (Fwd)
$-0.08
ROE
-81.6%
ROA
-9.1%
Cash
$639.1M
Total Debt
$1.32B
Free CF
-$55.8M
52W Change
-14.0%
Annual Financials
Cash vs Debt
Tempus AI, Inc. carries $1.32B in total debt against $639.1M in cash reserves — debt is roughly 2.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company is burning cash, with free cash flow at -$55.8M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -81.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $320.7M (2022) to $1.27B (2025), reflecting a 297% increase over the period.
With a beta above 1.5, TEM tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Tempus AI, Inc.'s trajectory.